AU4778500A - Composition containing ascorbic acid salt - Google Patents

Composition containing ascorbic acid salt

Info

Publication number
AU4778500A
AU4778500A AU47785/00A AU4778500A AU4778500A AU 4778500 A AU4778500 A AU 4778500A AU 47785/00 A AU47785/00 A AU 47785/00A AU 4778500 A AU4778500 A AU 4778500A AU 4778500 A AU4778500 A AU 4778500A
Authority
AU
Australia
Prior art keywords
composition containing
ascorbic acid
acid salt
containing ascorbic
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47785/00A
Inventor
Atsuko Hayano
Tadashi Makino
Hiroshi Matoba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU4778500A publication Critical patent/AU4778500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
AU47785/00A 1999-05-20 2000-05-19 Composition containing ascorbic acid salt Abandoned AU4778500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/139842 1999-05-20
JP13984299 1999-05-20
PCT/JP2000/003220 WO2000071097A1 (en) 1999-05-20 2000-05-19 Composition containing ascorbic acid salt

Publications (1)

Publication Number Publication Date
AU4778500A true AU4778500A (en) 2000-12-12

Family

ID=15254795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47785/00A Abandoned AU4778500A (en) 1999-05-20 2000-05-19 Composition containing ascorbic acid salt

Country Status (2)

Country Link
AU (1) AU4778500A (en)
WO (1) WO2000071097A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2318649T3 (en) 2000-10-20 2009-05-01 EISAI R&D MANAGEMENT CO., LTD. PROCEDURE FOR PREPARATION OF DERIVATIVES OF 4-FENOXI QUINOLINAS.
CN101337930B (en) 2003-11-11 2010-09-08 卫材R&D管理有限公司 Urea derivative preparation process
JP4848140B2 (en) * 2004-05-26 2011-12-28 武田薬品工業株式会社 Stabilized solid formulations containing vitamin Cs
US8969379B2 (en) * 2004-09-17 2015-03-03 Eisai R&D Management Co., Ltd. Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
WO2007015578A1 (en) 2005-08-02 2007-02-08 Eisai R & D Management Co., Ltd. Method for assay on the effect of vascularization inhibitor
CA2652442C (en) 2006-05-18 2014-12-09 Eisai R & D Management Co., Ltd. Antitumor agent for thyroid cancer
KR101472600B1 (en) 2006-08-28 2014-12-15 에자이 알앤드디 매니지먼트 가부시키가이샤 Antitumor agent for undifferentiated gastric cancer
CA2676796C (en) 2007-01-29 2016-02-23 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated gastric cancer
WO2009060945A1 (en) 2007-11-09 2009-05-14 Eisai R & D Management Co., Ltd. Combination of anti-angiogenic substance and anti-tumor platinum complex
EP2586443B1 (en) 2010-06-25 2016-03-16 Eisai R&D Management Co., Ltd. Antitumor agent using compounds having kinase inhibitory effect in combination
JP5578534B2 (en) * 2010-12-27 2014-08-27 富田製薬株式会社 Disintegrating core particles for pharmaceutical products
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2705950T3 (en) 2011-06-03 2019-03-27 Eisai R&D Man Co Ltd Biomarkers to predict and assess the responsiveness of subjects with thyroid and kidney cancer to lenvatinib compounds
CN104755463A (en) 2012-12-21 2015-07-01 卫材R&D管理有限公司 Amorphous form of quinoline derivative, and method for producing same
MX368099B (en) 2013-05-14 2019-09-19 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds.
JO3783B1 (en) 2014-08-28 2021-01-31 Eisai R&D Man Co Ltd Highly pure quinoline derivative and method for producing the same
DK3263106T3 (en) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd PROCESS FOR SUPPRESSING BITTERNESS OF QUINOLINE DERIVATIVES
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
CN107801379B (en) 2015-06-16 2021-05-25 卫材R&D管理有限公司 Anticancer agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2543683B2 (en) * 1985-12-13 1996-10-16 武田薬品工業株式会社 Sodium Vitamin Dragee
JP2995226B2 (en) * 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 Chewable tablets containing calcium

Also Published As

Publication number Publication date
WO2000071097A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
AU4831699A (en) Improved stable topical ascorbic acid compositions
AU4778500A (en) Composition containing ascorbic acid salt
AU5033800A (en) Ascorbic acid derivative composition for increasing cell renewal rate
AU6795600A (en) Gums containing antimicrobial agents
HUP0001471A3 (en) Pharmaceutical compositions containing amoxicilline and clavulanic acid potassium salt
AU4318000A (en) Agarobiose-containing composition
AU1290501A (en) Composition
AU5561800A (en) Sorbent composition
AU5622300A (en) Stable l-ascorbic acid composition
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
PL344999A1 (en) Phenyl-methoxyimino-acetic acid derivatives as pesticides
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU7293398A (en) A composition containing an ascorbic acid compound
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU4203900A (en) Method to identify antimicrobial agents
AU6310600A (en) Composition
AU3494199A (en) Transparent composition
AU3332199A (en) Phenyl-methoxyimino-glyoxylic acid derivatives as pesticides
AU4914400A (en) Novel pharmaceutical composition
AUPQ246999A0 (en) Insecticidal composition
AU5654399A (en) Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU5567600A (en) Hairdye composition
AU5289299A (en) Divinylstilbenesulfonic acid derivatives
AU6887600A (en) Composition for preventing iodine deficiency

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase